News

MorphoSys to receive clinical milestone payment.

Multi-year agreement to further develop a selective Kv1.5 modulator for the treatment of atrial fibrillation.

The study, a critical part of the EU funded MitoCare Project, will evaluate the reduction of reperfusion injury by TRO40303 in acute ST-elevation myocardial infarction (STEMI) patients.

Dr Philips has over 25 years of senior management and Board level experience in public and private companies across Europe, the US and Australia.

Stefan Oschmann to focus on role as Head of Pharmaceuticals in charge of Merck Serono, Consumer Health, Allergopharma and Biosimilars.

Cycling enthusiasts at the 28th European Crystallography Meeting (ECM) have used the occasion to raise money for Cancer Research.

Biocatalysis and metagenomics used for generation of improved hydrocolloids with potential therapeutic properties.

New market insight uncovers the latest technology trends and strategic approaches for biopharma CMOs.

NIH co-funded trial will build on results of landmark HPTN 052 study.

The drug, tested in mice, was found to slow the loss of coordination seen in the disorder extending the animals’ life span.